Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Fabio Settecase

Neuroradiology San Francisco, CA Medical Doctor

NPI 1942453618 CMS profile 788974

1100 Van Ness Ave, San Francisco, CA 94109

Open in the dashboard

General payments

$757,619

116 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$1,688,556

3 holdings reported · through program year 2025

Research they led as principal investigator

$18,222 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Fabio Settecase of San Francisco, CA is reported in the CMS Open Payments database as having received $757,619 across 116 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $18,222 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,688,556 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $346,561 18
2024 General $265,463 18
2023 General $112,259 14
2022 General $24,227 25
2021 General $8,868 37
2020 General $241 4
2025 Ownership $634,124 1
2024 Ownership $593,323 1
2023 Ownership $461,109 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fabio Settecase
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Fabio Settecase were reported at $346,561. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Fabio Settecase Neuroradiology median Middle half National median
2019 $0 $288 $71–$2,035 $163
2020 $241 $165 $32–$1,794 $114
2021 $8,868 $238 $42–$1,807 $132
2022 $24,227 $191 $49–$1,388 $149
2023 $112,259 $228 $56–$1,148 $160
2024 $265,463 $241 $97–$2,192 $164
2025 $346,561 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Route 92 Medical, Inc. $740,032 8 payments
  2. Stryker Corporation $15,489 89 payments
  3. Medtronic, Inc. $999 8 payments
  4. Atricure, Inc. $420 4 payments
  5. MicroVention, Inc. $330 3 payments
  6. Rapid Medical LTD $154 1 payment
  7. Balt USA, LLC $135 1 payment
  8. DePuy Synthes Sales Inc. $31 1 payment
  9. Penumbra, Inc. $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $751,017 14 payments
  2. Food and Beverage $5,788 98 payments
  3. Travel and Lodging $814 4 payments
Products named General payments · program years 2020–2025
  1. 8F BASE CAMP SHEATH SYSTEM $394,882 6 payments
  2. 088 ACCESS SYSTEM $20,957 2 payments
  3. SURPASS EVOLVE $5,250 34 payments
  4. AXS CATALYST 7 $3,857 3 payments
  5. WINGSPAN $3,606 6 payments
  6. SYNCHRO SELECT $3,389 4 payments
  7. GATEWAY $3,350 3 payments
  8. INFINITY $3,325 1 payment
  9. AXS VECTA 71 $2,626 10 payments
  10. TREVO $2,489 6 payments
  11. Other $5,352 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$38,646

Medicare's payments for the services billed

Medicare patients

81

Average age 76

Services billed

274

47 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 43%
Diabetes 36%
Heart failure 35%
Chronic kidney disease 35%
Atrial fibrillation 33%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record